Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04159896
Title ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute

prostate cancer


CEP-11981 + Nivolumab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.